Tracing cancer in blood via exosomes.

Novel platform technology ExoPheno  enabling the discovery and validation of disease-specific exosome subpopulations in biofluids. 


Disease-specific exosome targets

Exosomes are the future of routine disease detection

Circulating snapshot of disease biomarker cargo:

  • Constantly secreted by all living cells

  • Protected from enzymatic destruction

  • Found in all biofluids, including blood

Contain rare molecular information (-omics):

  • Proteins

  • RNA

  • Others

Novel exosome liquid biopsy platform ExoPheno


​Exosome Discovery technology, NPDiscover:

  • Method to isolate and sequence exosome sub-populations by origin and disease considering two specific surface markers (or more) via proprietary tagging and release

Exosome Validation technology, NPQuantumSense:

  • Method to trap and identify target exosomes in biofluid via quantum phenomena generated by proprietary nanogap electrodes



2021 Mursla Ltd.

181 Cambridge Science Park, CB4 0GJ, Cambridge, U.K.

  • Twitter - White Circle
  • LinkedIn - White Circle